Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.55
+0.05 (0.13%)
Oct 29, 2026, 11:58 AM EDT - Market open
HRMY Market Cap
HRMY has a market cap or net worth of $2.25 billion as of October 29, 2026. It is the 6,124th most valuable company in the world and the 1,698th biggest in the United States. Its market cap has increased by 31.65% in one year.
Market Cap
2.25B
Enterprise Value
1.74B
1-Year Change
31.65%
Global Rank
Country Rank
#1,698 United States
Category
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.25B, an increase of 386.95%. That is a compound annual growth rate of 29.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.25B | 4.16% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 2.32B |
| Biohaven | 2.31B |
| Aurinia Pharmaceuticals | 2.30B |
| Agios Pharmaceuticals | 2.27B |
| Pharvaris | 2.24B |
| Xencor | 2.23B |
| Vericel | 2.22B |
| Precigen | 2.20B |